Home

urto internazionale Disabilitare parthenolide clinical trial vanità urlare mattone

Pharmaceuticals | Free Full-Text | Parthenolide as Cooperating Agent for  Anti-Cancer Treatment of Various Malignancies
Pharmaceuticals | Free Full-Text | Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies

PDF] Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various  Malignancies | Semantic Scholar
PDF] Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies | Semantic Scholar

Pharmaceuticals | Free Full-Text | Parthenolide as Cooperating Agent for  Anti-Cancer Treatment of Various Malignancies
Pharmaceuticals | Free Full-Text | Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies

Tentative model for the mechanisms of parthenolide-mediated apoptosis... |  Download Scientific Diagram
Tentative model for the mechanisms of parthenolide-mediated apoptosis... | Download Scientific Diagram

PARTHENOLIDE
PARTHENOLIDE

Synthesis of dual-action parthenolide prodrugs as potent anticancer agents  - ScienceDirect
Synthesis of dual-action parthenolide prodrugs as potent anticancer agents - ScienceDirect

Production of Plant Sesquiterpene Lactone Parthenolide in the Yeast Cell  Factory | ACS Synthetic Biology
Production of Plant Sesquiterpene Lactone Parthenolide in the Yeast Cell Factory | ACS Synthetic Biology

Advances in chemistry and bioactivity of parthenolide - Natural Product  Reports (RSC Publishing) DOI:10.1039/C9NP00049F
Advances in chemistry and bioactivity of parthenolide - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00049F

Parthenolide: from plant shoots to cancer roots - ScienceDirect
Parthenolide: from plant shoots to cancer roots - ScienceDirect

Discovery of Potent Parthenolide-Based Antileukemic Agents Enabled by  Late-Stage P450-Mediated C—H Functionalization | ACS Chemical Biology
Discovery of Potent Parthenolide-Based Antileukemic Agents Enabled by Late-Stage P450-Mediated C—H Functionalization | ACS Chemical Biology

Frontiers | Collateral Sensitivity of Parthenolide via NF-κB and HIF-α  Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
Frontiers | Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines

DMAPT (Dimethylamino Parthenolide) | NF-κB Inhibitor | MedChemExpress
DMAPT (Dimethylamino Parthenolide) | NF-κB Inhibitor | MedChemExpress

Parthenolide generates reactive oxygen species and autophagy in MDA-MB231  cells. A soluble parthenolide analogue inhibits tumour growth and  metastasis in a xenograft model of breast cancer | Cell Death & Disease
Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer | Cell Death & Disease

Total Syntheses of Parthenolide and Its Analogues with Macrocyclic  Stereocontrol | Journal of Medicinal Chemistry
Total Syntheses of Parthenolide and Its Analogues with Macrocyclic Stereocontrol | Journal of Medicinal Chemistry

Parthenolide inhibits the growth of non-small cell lung cancer by targeting  epidermal growth factor receptor | Cancer Cell International | Full Text
Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor | Cancer Cell International | Full Text

Parthenolide is the Component of Tanacetum Parthenium that Inhibits  Nitroglycerin-Induced Fos Activation: Studies in an Animal Model of  Migraine - C Tassorelli, R Greco, P Morazzoni, A Riva, G Sandrini, G Nappi,
Parthenolide is the Component of Tanacetum Parthenium that Inhibits Nitroglycerin-Induced Fos Activation: Studies in an Animal Model of Migraine - C Tassorelli, R Greco, P Morazzoni, A Riva, G Sandrini, G Nappi,

Advances in chemistry and bioactivity of parthenolide - Natural Product  Reports (RSC Publishing) DOI:10.1039/C9NP00049F
Advances in chemistry and bioactivity of parthenolide - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00049F

Chemical structure of the sesquiterpene lactone parthenolide present in...  | Download Scientific Diagram
Chemical structure of the sesquiterpene lactone parthenolide present in... | Download Scientific Diagram

Parthenolide ((-)-Parthenolide) | NF-κB Inhibitor | MedChemExpress
Parthenolide ((-)-Parthenolide) | NF-κB Inhibitor | MedChemExpress

Synthesis and anti-acute myeloid leukemia activity of C-14 modified  parthenolide derivatives - ScienceDirect
Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives - ScienceDirect

Parthenolide is the Component of Tanacetum Parthenium that Inhibits  Nitroglycerin-Induced Fos Activation: Studies in an Animal Model of  Migraine - C Tassorelli, R Greco, P Morazzoni, A Riva, G Sandrini, G Nappi,
Parthenolide is the Component of Tanacetum Parthenium that Inhibits Nitroglycerin-Induced Fos Activation: Studies in an Animal Model of Migraine - C Tassorelli, R Greco, P Morazzoni, A Riva, G Sandrini, G Nappi,

Parthenolide ((-)-Parthenolide) | NF-κB Inhibitor | MedChemExpress
Parthenolide ((-)-Parthenolide) | NF-κB Inhibitor | MedChemExpress

Design and synthesis of parthenolide and 5-fluorouracil conjugates as  potential anticancer agents against drug resistant hepatocellular carcinoma  - ScienceDirect
Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma - ScienceDirect

Synthesis and antileukemic activities of C1–C10-modified parthenolide  analogues - ScienceDirect
Synthesis and antileukemic activities of C1–C10-modified parthenolide analogues - ScienceDirect

Parthenolide inhibits the tumor characteristics of renal cell carcinoma
Parthenolide inhibits the tumor characteristics of renal cell carcinoma

Cells | Free Full-Text | Costunolide and Parthenolide Ameliorate MPP+  Induced Apoptosis in the Cellular Parkinson’s Disease Model
Cells | Free Full-Text | Costunolide and Parthenolide Ameliorate MPP+ Induced Apoptosis in the Cellular Parkinson’s Disease Model